The Effect of Human Amniotic Membrane Allograft on Functional Recovery After Flexor Tendon Repair

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2016-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this pilot study is to gain observational insight into potential preventive features of amniotic membrane transplantation in the adhesion formation after flexor tendon repair.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bio ACL Reconstruction Amnion Collagen Matrix Wrap and Stem Cells

NCT03294759

ACL - Anterior Cruciate Ligament Rupture

ACTIVE_NOT_RECRUITING NA

MPFLR With Fascia Lata Allograft, Based on Isometry Assessment + Elmslie-Trillat TTO

NCT05868434

Lateral Patellofemoral Dislocation Closed Traumatic Lateral Patellar Luxation

RECRUITING NA

BioACL Reconstruction With Amnion Collagen Matrix Wrap and Stem Cells Case Series

NCT03294720

ACL - Anterior Cruciate Ligament Rupture

COMPLETED PHASE1

Reparation of Cartilage Injuries in the Human Knee by Implantation of Fresh Human Allogenic Chondrocytes

NCT00263432

Cartilage Injuries in the Human Knee

COMPLETED NA

Degenerative Meniscus Without Osteoarthritis : Arthroscopic Partial Menisectomy Versus Platelet Rich Plasma (APM-PRP)

NCT04972331

Meniscectomy Platelet-Rich Plasma Meniscus; Degeneration

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The treatment of flexor tendon transection consists of surgical apposition of the lacerated tendon ends using non-absorbable sutures. Main complications which result in poor outcome of the tendon repair are the rupture of the tendon apposition or substantial adhesion formation between the two tendons or the tendon and the fibro-osseous canal. Adhesion formation is presumed to be a byproduct of the tendon healing. In the course of last 70 decades, the preventive effects of several pharmacological agents and mechanical barriers on adhesion formation have been investigated with some promising findings. One of the mechanical barriers that has been proposed to be suitable for adhesion prevention is human amniotic membrane allograft. However, there are no clinical studies evaluating the use of amniotic membrane in flexor tendon repair.

This is a pilot study for the forthcoming randomized controlled study. The objectives of the pilot study are: 1) to test the handleability of the human amniotic membrane allograft in flexor tendon sheath reconstruction in conjunction with flexor tendon repair, 2) to elucidate the possible adverse effects related to the use of amniotic membrane in flexor the sheath, and 3) to gain observational insight into potential preventive features of amniotic membrane transplantation in the adhesion formation. The hypothesis of the pilot study is that the application of the human amniotic membrane allograft in tendon sheath reconstruction in flexor tendon injury patients is technically feasible and results in no adverse effects to the patient.

A total of 10 patients with an acute flexor tendon injury will be included in the pilot study. After conventional tendoraphia, the amniotic membrane will be wrapped around the tendons and its borders will be fixed to the remaining tendon sheath. The primary outcome measure is total range of movement after 6 months of the surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Flexor Tendon Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Amniotic membrane allograft group

After the conventional flexor tendon repair, the amniotic membrane will be wrapped around the tendons and its borders will be fixed to the remaining tendon sheath.

Group Type EXPERIMENTAL

The use of amnionic membrane allograft

Intervention Type PROCEDURE

After the conventional flexor tendon repair, the amniotic membrane will be wrapped around the tendons and its borders will be fixed to the remaining tendon sheath.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The use of amnionic membrane allograft

After the conventional flexor tendon repair, the amniotic membrane will be wrapped around the tendons and its borders will be fixed to the remaining tendon sheath.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute flexor tendon transection in zone 2 in digits 2, 3, 4, or 5 (diagnosed within 1 week after the injury)
* Age over 18
* Patient's willingness to participate in the study

Exclusion Criteria

* Tendon transection within 8 mm of its distal insertion (requiring reinsertion)
* Soft-tissue loss, severe crush, fracture, palmar plate injury, patient requiring revascularization
* Cognitive impairment or other factors (prisoner, military serviceman) which may affect one's decision making
* Substance abuse
* Pregnancy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No